Yoen-Ju Son

Principal Scientist
Merck Research Labs
Mehrdad Kheiripour
Yoen-Ju Son is currently at Merck focused on drug-device combination specialty drug product development. She is been in industry for about 11 years in drug product development for both early and late stage products, oral solids as well as respiratory. Her main interests and expertise include particle engineering for dry powder inhaled products, nasal drug delivery, innovative/alternate approaches to liquid biologic formulation and phase-appropriate risk assessment. Yoen-Ju has earned her PhD from The University of Texas at Austin in Pharmaceutics , and has previously worked at Novartis Pharmaceuticals.


No data was found